Common in vitro substrate specificity and differential Src homology 2 domain accessibility displayed by two members of the Src family of protein-tyrosine kinases, c-Src and Hck
- PMID: 9642231
- DOI: 10.1074/jbc.273.27.16756
Common in vitro substrate specificity and differential Src homology 2 domain accessibility displayed by two members of the Src family of protein-tyrosine kinases, c-Src and Hck
Abstract
Hck and Src are members of the Src family of protein- tyrosine kinases that carry out distinct and overlapping functions in vivo (Lowell, C. A., Niwa, M., Soriano, P., and Varmus, H. E. (1996) Blood 87, 1780-1792). In an attempt to understand how Hck and Src can function both independently and in concert, we have compared 1) their in vitro substrate specificity and 2) the accessibility of their Src homology 2 (SH2) domain. Using several synthetic peptides, we have demonstrated that Hck and Src recognize similar structural features in the substrate peptides, suggesting that both kinases have the intrinsic ability to carry out overlapping cellular functions by phosphorylating similar cellular proteins in vivo. Using a phosphotyrosine-containing peptide that has previously been shown to bind the SH2 domain of Src family kinases with high affinity, we found that although Src could bind to the phosphopeptide, Hck showed no interaction. The inability of Hck to bind the phosphopeptide was not a result of a stable intramolecular interaction between its SH2 domain and C-terminal regulatory phosphotyrosine residue (Tyr-520), as most Hck molecules in the purified Hck preparation were not tyrosine-phosphorylated. In contrast to intact Hck, a recombinant truncation analog of Hck was able to bind the phosphopeptide with an affinity similar to that of the Src SH2 domain, suggesting that conformational constraints are imposed on intact Hck that limit accessibility of its SH2 domain to the phosphopeptide. Furthermore, the difference in SH2 domain accessibility is a potential mechanism that enables Src and Hck to perform their respective unique functions by 1) targeting them to different subcellular compartments, whereupon they phosphorylate different cellular proteins, and/or 2) facilitating direct binding to their cellular substrates.
Similar articles
-
Reciprocal regulation of Hck activity by phosphorylation of Tyr(527) and Tyr(416). Effect of introducing a high affinity intramolecular SH2 ligand.J Biol Chem. 2000 Jan 28;275(4):2721-6. doi: 10.1074/jbc.275.4.2721. J Biol Chem. 2000. PMID: 10644735
-
Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.Biochemistry. 1996 Sep 10;35(36):11874-87. doi: 10.1021/bi9603940. Biochemistry. 1996. PMID: 8794770
-
Enhanced phosphorylation of Src family kinase substrates containing SH2 domain binding sites.J Biol Chem. 1998 Jun 19;273(25):15325-8. doi: 10.1074/jbc.273.25.15325. J Biol Chem. 1998. PMID: 9624111
-
Structures of Src-family tyrosine kinases.Curr Opin Struct Biol. 1997 Dec;7(6):777-85. doi: 10.1016/s0959-440x(97)80146-7. Curr Opin Struct Biol. 1997. PMID: 9434895 Review.
-
Biochemistry of the Src protein-tyrosine kinase: regulation by SH2 and SH3 domains.Recent Prog Horm Res. 1994;49:149-60. doi: 10.1016/b978-0-12-571149-4.50011-8. Recent Prog Horm Res. 1994. PMID: 7511826 Review.
Cited by
-
Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine.Cell Commun Signal. 2017 Aug 7;15(1):29. doi: 10.1186/s12964-017-0186-x. Cell Commun Signal. 2017. PMID: 28784162 Free PMC article.
-
Divergent modulation of Src-family kinase regulatory interactions with ATP-competitive inhibitors.ACS Chem Biol. 2014 Aug 15;9(8):1894-905. doi: 10.1021/cb500371g. Epub 2014 Jul 2. ACS Chem Biol. 2014. PMID: 24946274 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous